The peripheral cannabinoid receptor knockout mice: an update

被引:100
作者
Buckley, N. E. [1 ]
机构
[1] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA
关键词
cB(2)R; CB2R-/-; mice; antifibrogenic; pain; allergic dermatitis; atherosclerosis; chemotaxis; osteoporosis; multiple sclerosis;
D O I
10.1038/sj.bjp.0707527
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review gives an overview of the CB2 receptor (CB2R) knockout (CB2R-/-) mice phenotype and the work that has been carried out using this mutant mouse. Using the CB2R-/- mice, investigators have discovered the involvement of CB2R on immune cell function and development, infection, embryonic development, bone loss, liver disorders, pain, autoimmune inflammation, allergic dermatitis, atherosclerosis, apoptosis and chemotaxis. Using the CB2R-/- mice, investigators have also found that this receptor is not involved in cannabinoid-induced hypotension. In addition, the CB2R-/- mice have been used to determine specific tissue CB2R expression. The specificity of synthetic cannabinoid agonists, antagonists and anti-CB2R antibodies has been screened using tissues from CB2R-/- mice. Thus, the use of this mouse model has greatly helped reveal the diverse events involving the CB2R, and has aided in drug and antibody screening.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 92 条
[1]  
ALFERINK J, 2007, CB2 CANN REC BANFF A
[2]   Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study [J].
Ashton, JC ;
Friberg, D ;
Darlington, CL ;
Smith, PF .
NEUROSCIENCE LETTERS, 2006, 396 (02) :113-116
[3]   In silico patent searching reveals a new cannabinoid receptor [J].
Baker, D ;
Pryce, G ;
Davies, WL ;
Hiley, CR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (01) :1-4
[4]   Cannabinoids control spasticity and tremor in a multiple sclerosis model [J].
Baker, D ;
Pryce, G ;
Croxford, JL ;
Brown, P ;
Pertwee, RG ;
Huffman, JW ;
Layward, L .
NATURE, 2000, 404 (6773) :84-87
[5]   Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors [J].
Bátkai, S ;
Pacher, P ;
Járai, Z ;
Wagner, JA ;
Kunos, G .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (02) :H595-H600
[6]   Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis [J].
Bátkai, S ;
Járat, Z ;
Wagner, JA ;
Goparaju, SK ;
Varga, K ;
Liu, J ;
Wang, L ;
Mirshahi, F ;
Khanolkar, AD ;
Makriyannis, A ;
Urbaschek, R ;
Garcia, N ;
Sanyal, AJ ;
Kunos, G .
NATURE MEDICINE, 2001, 7 (07) :827-832
[7]   Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury [J].
Batkai, Sandor ;
Osei-Hyiaman, Douglas ;
Pan, Hao ;
El-Assal, Osama ;
Rajesh, Mohanraj ;
Mukhopadhyay, Partha ;
Hong, Feng ;
Harvey-White, Judith ;
Jafri, Anjum ;
Hasko, Gyorgy ;
Huffman, John W. ;
Gao, Bin ;
Kunos, George ;
Pacher, Pal .
FASEB JOURNAL, 2007, 21 (08) :1788-1800
[8]  
BENOWITZ NL, 1975, CLIN PHARMACOL THER, V18, P287
[9]   CANNABINOID-RECEPTOR EXPRESSION IN HUMAN-LEUKOCYTES [J].
BOUABOULA, M ;
RINALDI, M ;
CARAYON, P ;
CARILLON, C ;
DELPECH, B ;
SHIRE, D ;
LEFUR, G ;
CASELLAS, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 214 (01) :173-180
[10]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342